Drug Approval | January 20, 2022
VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis
First launches expected in H1 2022
First launches expected in H1 2022
This agreement allows Natco to expand access to Covid-19 medicines in 105 countries in generic name
The hospital will be operated under the name and style of Max Super Speciality Hospital, Dwarka
They will commercialize molnupiravir in the international markets
These results will be presented on 21 January at the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
New capabilities on Philips Image Guided therapy mobile C-arm system – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment
As part of Daiichi Sankyo’s 2030 vision, it plans to strengthen its oncology portfolio
The company has 271 cumulative ANDA filings with USFDA of which 243 ANDAs have been approved and 28 are pending approval
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
The last date to apply for this program is 18th January 2022
Subscribe To Our Newsletter & Stay Updated
